Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10Colonic Neoplasms 9Prostatic Neoplasms 8Colorectal Neoplasms 6Neoplasms 5Multiple Myeloma 4Uterine Cervical Neoplasms 3Stomach Neoplasms 3Smoldering Multiple Myeloma 3Rectal Neoplasms 3Pancreatic Neoplasms 3Monoclonal Gammopathy of Undetermined Significance 3Lung Neoplasms 3Adenomatous Polyposis Coli 3Uterine Cervical Dysplasia 2Radiodermatitis 2Pain 2Esophageal Neoplasms 2Breast Carcinoma In Situ 2cyclopia sequence 1Uterine Neoplasms 1Tuberous Sclerosis 1Thrombocythemia, Essential 1Stomatitis 1Sezary Syndrome 1Seizures 1Psychological Well-Being 1Prostate Cancer Metastatic Castration Resistant 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

pegfilgrastim 1lncRNA LNMAT1, human 1World Health Organization 1Watchful Waiting 1VCL-CB01 vaccine 1Taxes 1Symptom Assessment 1Paclitaxel 1Metformin 1Gastroscopy 1Drug Therapy 1Curcumin 1Chemotherapy, Adjuvant 1Carboplatin 1Blood Specimen Collection 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Communicable Diseases × Curcumin × Clear all
NCT02944578 2024-10-29

Topical Curcumin for Precancer Cervical Lesions

Emory University

Phase 2 Terminated
7 enrolled 7 charts

Communicable Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡